Analytical Data
-
基因名
CLCNKB
- Application
-
别名
Bartter syndrome type 3; Chloride channel Kb; Chloride channel kidney B; Chloride channel protein ClC-Kb; Chloride channel voltage sensitive Kb; ClC K2; ClC-K2; ClCK2; CLCKB; CLCKB_HUMAN; CLCNKB; hClC Kb
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P51801
-
表达区间
1-462aa
-
氨基酸序列
MEEFVGLREGSSGNPVTLQELWGPCPRIRRGIRGGLEWLKQKLFRLGEDWYFLMTLGVLMALVSCAMDLAVESVVRAHQWLYREIGDSHLLRYLSWTVYPVALVSFSSGFSQSITPSSGGSGIPEVKTMLAGVVLEDYLDIKNFGAKVVGLSCTLACGSTLFLGKVGPFVHLSVMMAAYLGRVRTTTIGEPENKSKPVYSALATLVLASITYPPSAGRFLASRLSMKQHLDSLFDNHSWALMTQNSSPPWPEELDPQHLWWEWYHPRFTIFGTLAFFLVMKFWMLILATTIPMPAGYFMPIFVYGAAIGRLFGETLSFIFPEGIVAGGITNPIMPGGYALAGAAAFSGAVTHTISTALLAFEVTGQIVHALPVLMAVLAANAIAQSCQPSFYDGTVIVKKLPYLPRILGRNIGSHRVRVEHFMNHSITTLAITLMNDEIGVHCHQGQAQMASGVVWFPVRGS
-
分子量
77 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CLCNKB, a member of the ClC family of chloride channels, plays a crucial role in maintaining ion homeostasis and cell volume regulation. Mutations in the CLCNKB gene are associated with Bartter syndrome type III, a genetic disorder characterized by hypokalemic metabolic alkalosis and impaired renal chloride reabsorption. Despite its importance in kidney function and electrolyte balance, the structural and functional mechanisms underlying CLCNKB's activities remain inadequately understood. Recent advancements in protein expression and purification techniques have enabled researchers to recombine CLCNKB into a functional form suitable for detailed biophysical and biochemical analyses. These studies aim to elucidate its ion transport mechanisms, interaction with regulatory proteins, and response to pharmacological agents. Understanding CLCNKB's properties may pave the way for novel therapeutic strategies targeting electrolyte imbalances and related disorders, offering insights into potential treatment options for Bartter syndrome and other renal dysfunctions. The ongoing research into the recombinant expression of CLCNKB emphasizes the channel's significance not only in basic science but also in its potential clinical implications, making it a compelling focus for further investigation in both pharmacology and molecular biology.
